Genetic testing can predict bladder cancer diagnosis years in advance

Published Date: 17 Mar 2023

Bladder cancer is not a rare disease. It is one of the 10 most common cancers in the UK and the 5th most common cancer in the European Union.

Read Full News

Latest News

Robotic Surgery May Help Restore Urine Control in Women

A robot-assisted procedure placing an artificial urinary sphincter may help women with stress incontinence achieve little or no urine leakage.

Many Men With LUTS Could Be Candidates to Stop Alpha-Blocker Treatment

— Novel N-of-1 study design showed minimal treatment effect for 11 of 30 patients

Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies

Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies

Latest Clinical Data for Emerging Combination Strategies in mHSPC

Latest Clinical Data for Emerging Combination Strategies in mHSPC

Redefining MIBC Standards: Multidisciplinary Insights on Optimizing Immunotherapy-Based Combinations

Redefining MIBC Standards: Multidisciplinary Insights on Optimizing Immunotherapy-Based Combinations

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Latest News

A robot-assisted procedure placing an artificial urinary sphincter may help women with stress incontinence achieve little or no urine leakage.

— Novel N-of-1 study design showed minimal treatment effect for 11 of 30 patients

Advancing Evidence-Based Care for Veterans With mHSPC: Pathways, Personalization, and Team-Based Strategies

Latest Clinical Data for Emerging Combination Strategies in mHSPC

Redefining MIBC Standards: Multidisciplinary Insights on Optimizing Immunotherapy-Based Combinations

Towards Personalized Treatment in mHSPC: Latest Evidence for Biomarker-Targeted Therapies and Multidisciplinary Toxicity Management

News All Time

Evidence Mounts for Darolutamide Plus ADT in Hormone-Sensitive Prostate Cancer

U.S. study supports findings from a global trial using an external control arm

He Inserted a Cable in His Penis. 10 Years Later, He Needed Surgery.

Patient in his 60s eventually developed sepsis

Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse

Significantly higher risk of sedative, opioid, cocaine abuse compared with no ED diagnosis

GLP-1 Drugs Linked to Significant Boost in Testosterone Levels for Men

Weight loss likely not the only reason for improvement, researcher says

Tibial Nerve Stimulation for Overactive Bladder Tied to Better Quality of Life

But main results from sham-controlled trial still outstanding

No Prostate Cancer Survival Benefit With More Extensive Lymph Node Assessment

Long-term follow-up consistent with earlier report, a hint of benefit in high-grade disease

Stoking Sexual Arousal and Desire: GLP-1s, Nerve Stimulation, 'Scream Cream'

GLP-1 agonists not helpful, may be harmful whereas neural, topical strategies often useful

Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline

Darolutamide offers "an option for preserving cognitive health" in advanced disease, expert says

The Blind Spot in Bladder Cancer Care: What Patients Don't Say

Patients and urologists are not always aligned on what the treatment experience will be like

In Search of Effective Treatment for Premature Ejaculation: 'I Really Have No Idea'

Lack of high-level evidence has hindered treatment development, but some patients do improve

FDA OKs Immunotherapy-BCG Combo for High-Risk Bladder Cancer

Combination significantly improved disease-free survival in phase III trial

Practice-Changing Trial in Prostate Cancer Shows Benefits of Perioperative Therapy

ADT plus apalutamide before and after surgery significantly improved metastasis-free survival

Treatment Intensification Slows Metastatic Hormone-Sensitive Prostate Cancer

Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alterations

Combating Cancer-Related Fatigue: Yoga, Bupropion, Exercise Plus Methylphenidate

Significant improvement with yoga and the atypical antidepressant

FDA's 'Big Dick Energy!' Warning; UHC Retreats on Prior Auth; Nurses Beat Ebola

Health news and commentary gathered by MedPage Today staff

FDA OKs Inflatable Penile Prosthesis for Erectile Dysfunction

Appearance and performance designed to emulate a natural erection

Recommended News For You

African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis

A garden can save your life

Chemoimmunotherapy Boosts Head and Neck Cancer Response

AI innovation unlocks non-surgical way to detect brain cancer spread

Black and Hispanic children with high-risk neuroblastoma have worse outcomes despite standardized treatment

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

Recommended Articles For You

Exploring the Impact of Adrenal Myelolipoma on the Human Body 

The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025 

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options  

Breast Cancer Secrets: AI-Powered Precision Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can certain food cravings predict a cancer diagnosis up to three months before other symptoms appear?

2.

U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain

3.

FDA approves Blenrep for relapsed or refractory multiple myeloma

4.

Scholastic performance is a key concern for young cancer patients, study finds

5.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

1.

The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy

2.

Integrated Insights in Hematology and Quality Improvement

3.

The Importance of Corrected Calcium Levels in Managing Health Conditions 

4.

Tumor Microenvironment Reprogramming for Regenerative Cancer Recovery

5.

Tumor Evolution Dynamics and Clinical Prognosis

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

4.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

5.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot